Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaodan Ding

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Blood Advances|February 27, 2019
The nuclear receptor corepressor NCoR1 regulates hematopoiesis and leukemogenesis in vivoXiaoling Wan, Lulu Liu, Peipei Zhou, et al.
Molecular Therapy. Methods & Clinical Development|December 11, 2025
CRISPR/methotrexate-integrated strategy for TCR-T cell engineering with reduced chromosome 14 lossJian Xu, Lianghua Shen, Ziyu Chen, et al.
Molecular Therapy. Advances|May 15, 2026
Erratum: CRISPR/methotrexate-integrated strategy for TCR-T cell engineering with reduced chromosome 14 lossJian Xu, Lianghua Shen, Ziyu Chen, et al.
Nature Communications|April 17, 2026
Mll5 haploinsufficiency attenuates microglial phagocytosis through dysregulated TREM2-SGK3-GSK3β signaling and recapitulates ASD-like behaviors in miceShumin Gao, Qingxiu Lin, Xiaotong Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 17, 2023
Circular mRNA-based TCR-T offers a safe and effective therapeutic strategy for treatment of cytomegalovirus infectionLianghua Shen, Jiali Yang, Chijian Zuo, et al.
Blood Advances|February 27, 2026
VLA-4 Agonist Promotes Engraftment and Immune Reconstitution of Allogeneic Hematopoietic Stem CellsQiaomei He, Xi Sun, Lin Veronica Chen, et al.
The Journal of Clinical Investigation|January 13, 2026
T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer modelsLianghua Shen, Ziyu Chen, Jian Xu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Blood Advances|February 27, 2019
The nuclear receptor corepressor NCoR1 regulates hematopoiesis and leukemogenesis in vivoXiaoling Wan, Lulu Liu, Peipei Zhou, et al.
Molecular Therapy. Methods & Clinical Development|December 11, 2025
CRISPR/methotrexate-integrated strategy for TCR-T cell engineering with reduced chromosome 14 lossJian Xu, Lianghua Shen, Ziyu Chen, et al.
Molecular Therapy. Advances|May 15, 2026
Erratum: CRISPR/methotrexate-integrated strategy for TCR-T cell engineering with reduced chromosome 14 lossJian Xu, Lianghua Shen, Ziyu Chen, et al.
Nature Communications|April 17, 2026
Mll5 haploinsufficiency attenuates microglial phagocytosis through dysregulated TREM2-SGK3-GSK3β signaling and recapitulates ASD-like behaviors in miceShumin Gao, Qingxiu Lin, Xiaotong Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 17, 2023
Circular mRNA-based TCR-T offers a safe and effective therapeutic strategy for treatment of cytomegalovirus infectionLianghua Shen, Jiali Yang, Chijian Zuo, et al.
Blood Advances|February 27, 2026
VLA-4 Agonist Promotes Engraftment and Immune Reconstitution of Allogeneic Hematopoietic Stem CellsQiaomei He, Xi Sun, Lin Veronica Chen, et al.
The Journal of Clinical Investigation|January 13, 2026
T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer modelsLianghua Shen, Ziyu Chen, Jian Xu, et al.
Pageof 3